Subscribe To
IBB / IBB: Healthcare Dashboard For April
IBB News
By See It Market
October 22, 2023
Stock Market ETFs to Watch: Semiconductors (SMH), Biotechnology (IBB), Regional Banks (KRE)
Most of you know our Big View product, since I often talk about our risk gauges. In fact, I can report to you that our risk gauges show 3 out of the more_horizontal
By Zacks Investment Research
September 29, 2023
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
The iShares Biotechnology ETF (IBB) was launched on 02/05/2001, and is a smart beta exchange traded fund designed to offer broad exposure to the Healt more_horizontal
By Zacks Investment Research
September 20, 2023
Should You Invest in the iShares Biotechnology ETF (IBB)?
Designed to provide broad exposure to the Healthcare - Biotech segment of the equity market, the iShares Biotechnology ETF (IBB) is a passively manage more_horizontal
By Seeking Alpha
August 30, 2023
IBB: The Illness Of Idiosyncratic Risk
The biotechnology sector has disappointed overall; we think there are better ways to get exposure to the healthcare sector. iShares Biotechnology ETF more_horizontal
By See It Market
August 22, 2023
Sector ETF Spotlight: $IBB Biotechnology on Drugs
Biotechnology has traded basically sideways since the start of 2023. In the face of higher rates, stronger dollar, inflation, FDA approvals and busts, more_horizontal
By Zacks Investment Research
July 24, 2023
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
The iShares Biotechnology ETF (IBB) made its debut on 02/05/2001, and is a smart beta exchange traded fund that provides broad exposure to the Health more_horizontal
By Zacks Investment Research
July 19, 2023
Should You Invest in the iShares Biotechnology ETF (IBB)?
Launched on 02/05/2001, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund designed to provide a broad exposure to the He more_horizontal
By Market Watch
June 22, 2023
PaxMedia hires ShareIntel to look into recent stock weakness, after a 45% plunge amid an 8-day losing streak
Shares of PaxMedia Inc. PXMD, -11.91% bounced 2.0% in premarket trading Thursday, after the biopharmaceutical company, which focuses on treatments of more_horizontal